mechlorethamine has been researched along with Leukemia in 184 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 9.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "Among these, leukemia is extremely common, and thus, developing novel drugs to combat leukemia is crucial." | 5.72 | Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx. ( Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X, 2022) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 5.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| " Patients were randomized in the Southwest Oncology Group (later the Pediatric Oncology Group [POG] to involved-field (IF) radiotherapy alone or IF radiotherapy followed by six courses of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) chemotherapy; patients in the Children's Cancer Study Group (CCSG) and Cancer and Leukemia Group B (CALGB) were randomized to receive extended-field (EF) radiotherapy or IF radiotherapy followed by six courses of MOPP." | 5.06 | The intergroup Hodgkin's disease in children. A study of stages I and II. ( Fryer, C; Fuller, LM; Gehan, EA; Gilchrist, GS; Hanson, W; Hays, DM; Heller, R; Johnston, J; Kennedy, P; Sullivan, MP, 1990) |
| " After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias." | 4.78 | Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991) |
| " The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents." | 4.77 | Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985) |
| "In addition to mechlorethamine, lomustine and teniposide combinations were also linked to an elevated risk of developing leukemia." | 3.69 | Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. ( Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE, 1994) |
| " Human chronic myelogenous leukemia K-562 cells were efficiently transduced with the N2Yc retrovirus vector and showed a significant increase in the 50% inhibitory concentration of chlorambucil (3." | 3.69 | Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells. ( Cournoyer, D; Greenbaum, M; Letourneau, S, 1996) |
| "The effect of morphine and cocaine on the transport of hydrolyzed nitrogen mustard (NH2-OH) and choline by peripheral blood cells of normal subjects and patients with chronic lymphocytic leukemia, acute lymphoblastic leukemia, and acute myeloblastic leukemia was determined." | 3.65 | Drug-induced stimulation of transport of hydrolyzed nitrogen mustard and choline by normal and leukemic human cells in vitro. ( Goldenberg, GJ, 1976) |
| "Cancer is considered one of the gruelling challenges and poses a grave health hazard across the globe." | 2.82 | Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy. ( Karati, D; Kumar, D; Mahadik, KR; Trivedi, P, 2022) |
| "Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches." | 2.37 | Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985) |
| "The prognosis of patients with Hodgkin's disease has dramatically improved over the past few decades." | 2.37 | Current management of Hodgkin's disease. ( Behrens, BC; DeVita, VT; Young, RC, 1985) |
| "Among these, leukemia is extremely common, and thus, developing novel drugs to combat leukemia is crucial." | 1.72 | Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx. ( Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X, 2022) |
| "Concerning ANLL, the MOPP regimen was significantly associated with a higher risk: 3." | 1.31 | Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. ( Andrieu, JM; Colonna, P; Delwail, V; Jais, JP, 2002) |
| "Patients treated for Hodgkin's disease have an increased risk of developing subsequent acute leukemia." | 1.30 | The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998) |
| " All other disease stages will require a different strategy that should consist of radiotherapy combined with short-term effective regimens, such as ABVD (doxorubicin, bleomycin, vinblastine and decarbazine) or VBM (vinblastine, bleomycin and methotrexate) to reduce the incidence of MOPP-associated gonadal dysfunction and leukaemogenesis." | 1.28 | Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. ( Banfi, A; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Tesoro Tess, JD; Valagussa, P; Viviani, S; Zanini, M; Zucali, R, 1992) |
| "3 microM, ethacrynic acid was toxic to 8 of 24 (33%) tumor specimens studied." | 1.28 | Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues. ( Kern, DH; Messenger, JC; Nagourney, RA; Weisenthal, LM, 1990) |
| "Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease." | 1.27 | Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984) |
| "Patients who had a relapse of Hodgkin's disease did not have an increased incidence of second malignancy." | 1.27 | Second malignancy complicating Hodgkin's disease. ( Mercier, JP; Tawil, E, 1983) |
| "Menadiol was tested alone and in combination with standard antineoplastic agents." | 1.27 | Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms. ( Dill, PL; Duarte, TE; Su, YZ; Weisenthal, LM, 1987) |
| "Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow." | 1.27 | Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985) |
| "Stage II Hodgkin's disease probably should be divided into two substages requiring different treatment." | 1.26 | [The current state of curability of Hodgkin's disease]. ( Streuli, RA; Ultmann, JE, 1981) |
| "We studied 680 patients with Hodgkin's disease, treated at Stanford University Medical Center from July 1, 1968, through December 31, 1975, to determine the risk of development of hematologic neoplasia." | 1.26 | Hematologic neoplasia in patients treated for Hodgkin's disease. ( Coleman, CN; Flint, A; Glatstein, EJ; Kaplan, HS; Rosenberg, SA; Williams, CJ, 1977) |
| "Urethane is the best treatment available for multiple myeloma." | 1.23 | New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 165 (89.67) | 18.7374 |
| 1990's | 14 (7.61) | 18.2507 |
| 2000's | 3 (1.63) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (1.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, T | 1 |
| Lin, L | 1 |
| Chen, H | 1 |
| Lu, W | 1 |
| Yang, X | 1 |
| Yang, L | 1 |
| Liu, Y | 1 |
| Cui, J | 1 |
| Sun, D | 1 |
| Karati, D | 1 |
| Mahadik, KR | 1 |
| Trivedi, P | 1 |
| Kumar, D | 1 |
| ERSLEV, A | 1 |
| WINTROBE, MM | 4 |
| HUGULEY, CM | 3 |
| BURCHENAL, JH | 5 |
| LESTER, RA | 1 |
| GOODMAN, LS | 2 |
| SYKES, MP | 1 |
| IRWIN, GE | 1 |
| MARLOW, AA | 1 |
| BARTLETT, GR | 1 |
| RUNDLES, RW | 1 |
| BARTON, WB | 1 |
| COONRAD, EV | 1 |
| KLIMA, R | 1 |
| HORNISCHER, R | 1 |
| HOLY, J | 1 |
| SUCHAN, M | 1 |
| MORELLI, A | 1 |
| MAUREA, C | 1 |
| KUROYANAGI, S | 1 |
| INTROZZI, P | 2 |
| MARINONE, G | 2 |
| HOLTHAUS, JM | 1 |
| BEATTIE, JW | 1 |
| HOWELLS, LH | 1 |
| CAKMAKCI, A | 1 |
| RAMIOUL, H | 1 |
| TOKUOKA, S | 1 |
| SELLEI, C | 2 |
| ECKHARDT, S | 2 |
| HARTAI, F | 1 |
| DUMBOVICH, B | 1 |
| BERNARD, J | 2 |
| MATHE, G | 2 |
| WEIL, M | 3 |
| HANSEN, PB | 1 |
| HORLIN, W | 1 |
| SCHMITT, W | 1 |
| HELLENDOORN, HB | 1 |
| PELT, M | 1 |
| GERBRANDY, J | 1 |
| LAMY, P | 1 |
| REMIGY, E | 1 |
| STEHLIN, H | 1 |
| KRAKOFF, IH | 1 |
| KARNOFSKY, DA | 2 |
| ZULIK, R | 1 |
| LOVISETTO, P | 1 |
| CASTELLANO, M | 1 |
| SCHREK, R | 2 |
| FRIEDMAN, IA | 1 |
| LEITHOLD, L | 1 |
| SZENTKLARAY, J | 1 |
| CHILOV, K | 2 |
| IVANOV, S | 2 |
| KIRCHEV, P | 1 |
| BLOCK, M | 2 |
| MOKEEVA, RA | 1 |
| VISHNIAKOVA, EG | 1 |
| DIAMOND, HD | 1 |
| DOAN, CA | 1 |
| WISEMAN, BK | 1 |
| BOURONCLE, BA | 1 |
| LAWKOWICZ, W | 1 |
| BECALSKI, J | 1 |
| BARLOW, AM | 1 |
| LEEMING, JT | 1 |
| WILKINSON, JF | 3 |
| GALTON, DA | 1 |
| WILTSHAW, E | 1 |
| SZUR, L | 1 |
| DACIE, JV | 1 |
| PISANI, A | 2 |
| POGGI, C | 2 |
| MEARDI, G | 2 |
| ARMAGHAN, V | 1 |
| GERHARTZ, H | 1 |
| WIEDEMANN, H | 1 |
| SPRAGUE, CC | 1 |
| THEOLOGIDES, A | 1 |
| KENNEDY, BJ | 1 |
| HARRINGTON, WJ | 2 |
| HALLORAN, MJ | 1 |
| KIRCHOFF, VG | 1 |
| REINHARD, EH | 1 |
| GROSSMAN, R | 1 |
| WHITE, B | 1 |
| HILGER, E | 1 |
| SAMPEY, JR | 6 |
| KOJIMA, M | 1 |
| NAKAMOTO, S | 1 |
| KOLFF, WJ | 1 |
| EVANS, AM | 1 |
| RIEKHOF, P | 1 |
| IMAMURA, S | 1 |
| NAKAKUKI, K | 1 |
| KATCHMAN, BJ | 1 |
| ZIPF, RE | 1 |
| MURPHY, JP | 1 |
| JEN, YF | 1 |
| STEFANI, S | 1 |
| DOCTOR, VM | 1 |
| DE BERGSAGEL, DE | 1 |
| SHULLENBERGER, CC | 1 |
| ADAMS, JL | 1 |
| MATSUOKA, M | 1 |
| CREPALDI, G | 1 |
| PARPAJOLA, A | 1 |
| BURNINGHAM, RA | 1 |
| RESTREPO, A | 1 |
| PUGH, RP | 1 |
| BROWN, EB | 1 |
| SCHLOSSMAN, SF | 1 |
| KHURI, PD | 1 |
| LESSNER, HE | 1 |
| DIAMANDOPOULOS, GT | 1 |
| SMITH, EB | 1 |
| DUNNING, WF | 1 |
| CURTIS, MR | 1 |
| DOWD, JE | 1 |
| DIPAOLO, JA | 1 |
| WATNE, AL | 1 |
| IRIARTE, P | 1 |
| JAGASIA, H | 1 |
| THURMAN, WG | 2 |
| FRIEDMAN, OM | 1 |
| BOGER, E | 1 |
| GRUBLIAUSKAS, V | 1 |
| SOMMER, H | 1 |
| HUTCHISON, JL | 1 |
| TSOU, KC | 1 |
| SU, HC | 1 |
| CORREA, JN | 1 |
| ANDREWS, JR | 1 |
| DUHIG, JT | 1 |
| KEIDAN, SE | 1 |
| MAINWARING, D | 1 |
| SMITH, JC | 1 |
| BOLANDE, RP | 1 |
| CONKLIN, JW | 1 |
| UPTON, AC | 1 |
| CHRISTENBERRY, KW | 1 |
| GREEN, RA | 1 |
| DIXON, H | 1 |
| MORROW, LB | 1 |
| ANDERSON, RE | 1 |
| VESIN, S | 1 |
| LIBANSKY, J | 1 |
| CHUDOMEL, V | 1 |
| BRABEC, V | 1 |
| SOCHMAN, J | 1 |
| SANDOR, L | 1 |
| CERNY, V | 1 |
| UJHAZY, V | 1 |
| WINKLER, A | 1 |
| NEMETH, L | 1 |
| GAL, F | 1 |
| PORTER, FS | 1 |
| HOLOWACH, J | 1 |
| RUNDLES, W | 1 |
| GRIZZLE, J | 1 |
| BONO, VH | 1 |
| JONSSON, U | 1 |
| CORLEY, CC | 1 |
| WEICKER, H | 1 |
| LINDEMANN, M | 1 |
| GUMMEL, H | 1 |
| GARDIKAS, C | 2 |
| BURCHENAL, JR | 1 |
| JOHNSTON, SF | 1 |
| SIEBEROVA-KLIMOVA, R | 1 |
| NINNI, M | 1 |
| LEVI, M | 1 |
| MENE, G | 1 |
| FERRI, A | 1 |
| CAPPELLO, F | 1 |
| de LORENZO, J | 1 |
| JANNINI, P | 1 |
| ABOU SINNA, I | 1 |
| SZREDER, W | 1 |
| MIGDALSKA, Z | 1 |
| KIELER, J | 1 |
| TAZAKI, Y | 1 |
| FUCHIGAMI, A | 1 |
| OOTA, K | 1 |
| INGRASSIA, G | 1 |
| VASILE, B | 1 |
| MELICK, RA | 1 |
| STORTI, E | 1 |
| KEIBL, E | 1 |
| SPITZY, KH | 1 |
| STORCH, L | 1 |
| JANBON, M | 1 |
| BERTRAND, L | 1 |
| PEDERSEN, E | 1 |
| PAVAN, S | 1 |
| MATTHEWS, WB | 1 |
| SPURR, CL | 2 |
| SMITH, TR | 1 |
| JACOBSON, LO | 1 |
| von KRESS, H | 1 |
| Johnson, EP | 1 |
| MYERS, WP | 1 |
| BEN-ASHER, S | 1 |
| LEVIN, WC | 1 |
| HOLT, JG | 1 |
| Valagussa, P | 2 |
| Santoro, A | 3 |
| Fossati Bellani, F | 1 |
| Franchi, F | 1 |
| Banfi, A | 2 |
| Bonadonna, G | 4 |
| Freireich, EJ | 1 |
| Keating, M | 1 |
| Cabanillas, F | 1 |
| Barlogie, B | 1 |
| Dameshek, W | 1 |
| Goodman, MJ | 1 |
| Gilman, A | 1 |
| McLennan, MT | 1 |
| Körbling, M | 1 |
| Hunstein, W | 1 |
| Vorob'ev, AI | 1 |
| Brilliant, MD | 1 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Tester, WJ | 1 |
| Kinsella, TJ | 1 |
| Waller, B | 1 |
| Makuch, RW | 1 |
| Kelley, PA | 1 |
| Glatstein, E | 2 |
| DeVita, VT | 5 |
| Jacquillat, C | 1 |
| Auclerc, G | 1 |
| Auclerc, MF | 1 |
| Maral, J | 1 |
| Tawil, E | 1 |
| Mercier, JP | 1 |
| Aisenberg, AC | 1 |
| Gassmann, W | 1 |
| Schmitz, N | 1 |
| Löffler, H | 1 |
| Gomez, GA | 1 |
| Aggarwal, KK | 1 |
| Han, T | 1 |
| Streuli, RA | 1 |
| Ultmann, JE | 1 |
| Nagourney, RA | 2 |
| Evans, SS | 1 |
| Messenger, JC | 2 |
| Su, YZ | 2 |
| Weisenthal, LM | 3 |
| van Leeuwen, FE | 1 |
| Chorus, AM | 1 |
| van den Belt-Dusebout, AW | 1 |
| Hagenbeek, A | 2 |
| Noyon, R | 1 |
| van Kerkhoff, EH | 1 |
| Pinedo, HM | 1 |
| Somers, R | 1 |
| Fabbri, S | 1 |
| Prontera, C | 1 |
| Broggini, M | 1 |
| D'Incalci, M | 1 |
| Letourneau, S | 1 |
| Greenbaum, M | 1 |
| Cournoyer, D | 1 |
| Schellong, G | 1 |
| Riepenhausen, M | 1 |
| Creutzig, U | 1 |
| Ritter, J | 1 |
| Harbott, J | 1 |
| Mann, G | 1 |
| Gadner, H | 1 |
| Brusamolino, E | 1 |
| Anselmo, AP | 1 |
| Klersy, C | 1 |
| Santoro, M | 1 |
| Orlandi, E | 1 |
| Pagnucco, G | 1 |
| Lunghi, F | 1 |
| Maurizi-Enrici, R | 1 |
| Baroni, CD | 1 |
| Lazzarino, M | 1 |
| Mandelli, F | 1 |
| Bernasconi, C | 1 |
| Cellai, E | 1 |
| Magrini, SM | 1 |
| Masala, G | 1 |
| Alterini, R | 1 |
| Costantini, AS | 1 |
| Rigacci, L | 1 |
| Olmastroni, L | 1 |
| Papi, MG | 1 |
| Spediacci, MA | 1 |
| Innocenti, F | 1 |
| Bellesi, G | 1 |
| Ferrini, PR | 1 |
| Biti, G | 1 |
| Avilés, A | 3 |
| Neri, N | 1 |
| Delwail, V | 1 |
| Jais, JP | 1 |
| Colonna, P | 1 |
| Andrieu, JM | 1 |
| Garrett, MJ | 1 |
| Das, S | 1 |
| Smith, JD | 1 |
| Freedman, LS | 1 |
| Nissen, NI | 2 |
| Pajak, TF | 1 |
| Glidewell, O | 1 |
| Pedersen-Bjergaard, J | 2 |
| Stutzman, L | 1 |
| Falkson, G | 1 |
| Cuttner, J | 1 |
| Blom, J | 1 |
| Leone, L | 1 |
| Sawitsky, A | 1 |
| Coleman, M | 1 |
| Haurani, F | 1 |
| Harley, JB | 1 |
| Seligman, B | 1 |
| Cornell, C | 1 |
| Henry, P | 1 |
| Senn, HJ | 1 |
| Brunner, K | 1 |
| Martz, G | 1 |
| Maurice, P | 1 |
| Bank, A | 1 |
| Shapiro, L | 1 |
| James, GW | 1 |
| Holland, JF | 1 |
| Coleman, CN | 1 |
| Williams, CJ | 1 |
| Flint, A | 1 |
| Glatstein, EJ | 1 |
| Rosenberg, SA | 1 |
| Kaplan, HS | 1 |
| Goldenberg, GJ | 1 |
| Díaz-Maqueo, JC | 2 |
| Ayala, JR | 1 |
| Cortés, HD | 1 |
| García, EL | 2 |
| Hall, AG | 1 |
| Tilby, MJ | 1 |
| Bonfante, V | 1 |
| Viviani, S | 1 |
| Zucali, R | 1 |
| Devizzi, L | 1 |
| Zanini, M | 1 |
| Tesoro Tess, JD | 1 |
| Kern, DH | 1 |
| Talavera, A | 1 |
| Guzmán, R | 1 |
| Longo, DL | 3 |
| Duffey, PL | 2 |
| Wiernik, PH | 1 |
| Hubbard, SM | 2 |
| Phares, JC | 1 |
| Bastian, AW | 1 |
| Jaffe, ES | 2 |
| Young, RC | 4 |
| Petru, E | 1 |
| Schmähl, D | 1 |
| Gehan, EA | 1 |
| Sullivan, MP | 1 |
| Fuller, LM | 1 |
| Johnston, J | 1 |
| Kennedy, P | 1 |
| Fryer, C | 1 |
| Gilchrist, GS | 1 |
| Hays, DM | 1 |
| Hanson, W | 1 |
| Heller, R | 1 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Sagher, D | 1 |
| Karrison, T | 1 |
| Schwartz, JL | 1 |
| Larson, R | 1 |
| Meier, P | 1 |
| Strauss, B | 1 |
| Ihde, DC | 1 |
| Straus, DJ | 1 |
| Boccaccio, P | 1 |
| Rosa, F | 1 |
| Casciaro, S | 1 |
| D'Elia, P | 1 |
| Romagnoli, M | 1 |
| Ghio, R | 1 |
| España, P | 1 |
| Bonilla, F | 1 |
| Yebra, M | 1 |
| Diego, J | 1 |
| Alvarez de Mon, M | 1 |
| Marazuela, M | 1 |
| Durántez, A | 1 |
| Rowland, KM | 1 |
| Murthy, A | 1 |
| Duarte, TE | 1 |
| Dill, PL | 1 |
| Sizoo, W | 1 |
| Löwenberg, B | 1 |
| Blayney, DW | 1 |
| Greene, MH | 1 |
| Postal, MG | 1 |
| Rusthoven, JJ | 1 |
| MacKenzie, R | 1 |
| Virgolini, L | 1 |
| Behrens, BC | 1 |
| Ersbøll, J | 1 |
| Sørensen, HM | 1 |
| Keiding, N | 1 |
| Larsen, SO | 1 |
| Philip, P | 1 |
| Larsen, MS | 1 |
| Schultz, H | 1 |
| Carbone, PP | 1 |
| Trepel, F | 1 |
| Stockhusen, G | 1 |
| Rastetter, J | 1 |
| Begemann, H | 1 |
| Frei, E | 2 |
| Schabel, FM | 1 |
| Goldin, A | 1 |
| Rubin, P | 1 |
| Pruzanski, W | 1 |
| Saito, S | 1 |
| Benckhuijsen, C | 1 |
| Silber, R | 1 |
| Unger, KW | 1 |
| Ellman, L | 1 |
| Berceanu, S | 1 |
| Gociu, M | 1 |
| Geib, R | 1 |
| Sighetea, E | 1 |
| Dăncescu, I | 1 |
| Segal, E | 1 |
| Tănăsescu, C | 1 |
| Leikin, S | 1 |
| Brubaker, C | 1 |
| Hartmann, J | 1 |
| Murphy, ML | 1 |
| Wolff, J | 1 |
| Fennelly, JJ | 1 |
| Bishop, RC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474] | 400 participants (Anticipated) | Observational [Patient Registry] | 2003-07-31 | Recruiting | |||
| (PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088] | Phase 2 | 63 participants (Actual) | Interventional | 2010-06-24 | Terminated (stopped due to Lack of Accrual) | ||
| Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708] | Phase 3 | 146 participants (Actual) | Interventional | 2010-04-08 | Completed | ||
| A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodg[NCT00479167] | Phase 2 | 1 participants (Actual) | Interventional | 2007-05-31 | Terminated (stopped due to Lack of accrual and interest in study) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01453088)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 27 |
| Auto Transplant High Dose Melphalan+Bortezomib | 27 |
Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 13 |
| Auto Transplant High Dose Melphalan+Bortezomib | 11 |
14 reviews available for mechlorethamine and Leukemia
| Article | Year |
|---|---|
Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy.
Topics: Alkylating Agents; Antineoplastic Agents; Antineoplastic Agents, Alkylating; DNA; Humans; Leukemia; | 2022 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor | 1984 |
In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy.
Topics: Acute Disease; Animals; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Disease Models, | 1984 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Hodgkin's disease: long-term effects of therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Female; Genitalia, Fem | 1986 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
[Neutrophil leukemia. Review of the literature].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Busulfan; Fema | 1985 |
Current management of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
Topics: Anilides; Animals; Cell Division; Cyclophosphamide; Cytarabine; DNA, Neoplasm; Fluorouracil; Humans; | 1969 |
8 trials available for mechlorethamine and Leukemia
| Article | Year |
|---|---|
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug | 1982 |
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 1997 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1979 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re | 1991 |
The intergroup Hodgkin's disease in children. A study of stages I and II.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgki | 1990 |
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1988 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
164 other studies available for mechlorethamine and Leukemia
| Article | Year |
|---|---|
Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; DNA Damage; Glutathione Peroxidase | 2022 |
Treatment Of Malignant Blood Diseases and Cancer With Nitrogen Mustard Gas In U.S.A.; Review Article.
Topics: Leukemia; Mechlorethamine | 1948 |
Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Plant; Nitrogen | 1948 |
Studies on the chemotherapy of leukemia; effect of certain nitrogen mustards and carbamates on transmitted mouse leukemia.
Topics: Anti-Anxiety Agents; Carbamates; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1948 |
The newer nitrogen mustards in the treatment of leukemia.
Topics: Ethylamines; Leukemia; Mechlorethamine | 1948 |
Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1947 |
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: Amines; Gas Poisoning; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechloret | 1946 |
Treatment of the leukemias and lymphomas; current trends.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1952 |
Recent advances in treatment of leukemias and lymphomas.
Topics: Humans; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple | 1953 |
The role of chemotherapy in the management of malignant lymphomas and leukemias.
Topics: Adrenocorticotropic Hormone; Cortisone; Disease Management; Folic Acid Antagonists; Humans; Leukemia | 1953 |
[Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
Topics: Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymp | 1953 |
[Therapeutic effect of small doses of chloroethylaminohydrochloride associated with roentgenotherapy in blastomatosis].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Ray Therapy | 1953 |
[Eosinophilic leukemia].
Topics: Adrenocorticotropic Hormone; Hypereosinophilic Syndrome; Leukemia; Mechlorethamine; Nitrogen Mustard | 1953 |
[A case of chronic myelogenous leucaemia treated with nitrogen mustard N-oxide].
Topics: Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Mechlorethamine; Nitr | 1953 |
[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
Topics: Ethylamines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1953 |
Chemotherapy of lymphomas and leukemia.
Topics: Adrenocorticotropic Hormone; Cortisone; Folic Acid Antagonists; Humans; Leukemia; Lymphoma; Mechlore | 1954 |
Biological actions and therapeutic applications of nitrogen mustard.
Topics: Hodgkin Disease; Leukemia; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitr | 1954 |
[Triethylene melamine treatment of leukemia and lymphogranulomatosis].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis; Triethylenemela | 1954 |
Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia.
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
[Leukemia-like changes in mice administered with nitrogen mustard N-oxide (nitromin)].
Topics: Animals; Leukemia; Leukemia, Experimental; Mechlorethamine; Mice; Nitrogen Mustard Compounds | 1955 |
Clinical trial of a new nitrogen-mustard compound.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Mechlorethamine; Nitrogen; Nitrogen Mustard Compounds | 1956 |
[Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoid Tiss | 1956 |
Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
Topics: Chlorambucil; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Mechlorethamine; | 1957 |
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen | 1957 |
[Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1957 |
[Biochemical changes in induced cytolysis].
Topics: Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Radiotherapy | 1957 |
[Severe terminal purpura during CB 1348 therapy of chronic lymphoid leukemia].
Topics: Chlorambucil; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Mechlorethamine; | 1957 |
Remissions induced by chlorambucil in chronic granulocytic leukemia.
Topics: Chlorambucil; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mechlorethamine; Neoplasms | 1958 |
[Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustar | 1958 |
[P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1958 |
Variability of the in vitro sensitivity of human leukemic lymphocytes to x-rays and chemotherapeutic agents.
Topics: Humans; In Vitro Techniques; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mechlorethamine; Nitrogen Mu | 1958 |
[Therapeutic procedures for ambulatory treatment of hemoblastosis and malignant neoplasms].
Topics: Ascorbic Acid; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Vitamin A | 1958 |
[Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
Topics: Antineoplastic Agents; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compo | 1957 |
Histopathologic effects of x-rays, radiophosphorus, nitrogen mustard, urethane, and steroids upon the spleen in leukemias and lymphomas.
Topics: Adrenocorticotropic Hormone; Cortisone; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compou | 1958 |
[Result of use of dopan in treatment of chronic myeloleukosis].
Topics: Humans; Leukemia; Leukemia, Myeloid; Mechlorethamine; Nitrogen Mustard Compounds; Uracil; Uracil Mus | 1958 |
[Lymphoid leukemia treated by the combination of cortisone, CB 1348 & transfusions].
Topics: Blood Transfusion; Chlorambucil; Cortisone; Leukemia; Leukemia, Lymphoid; Mechlorethamine; Nitrogen | 1958 |
[First results of dopane therapy of chronic myeloid leukemia and of certain malignant tumors].
Topics: Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Mechlorethami | 1958 |
Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1958 |
Clinical evaluation of CB 1348 in leukemias and lymphomas.
Topics: Chlorambucil; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
[Observations on the application of CB-1348 in lymphatic leukemias].
Topics: Chlorambucil; Humans; Leukemia; Leukemia, Lymphoid; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
Topics: Leukemia; Mannitol; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Polycythem | 1959 |
The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia.
Topics: Adrenal Cortex Hormones; Chlorambucil; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leu | 1961 |
[The effect of nitrogen mustard on the oxygen consumption of the leukocytes in chronic myeloid leukemia].
Topics: Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; M | 1960 |
[The effect of nitrogen mustard on the oxygen consumption of the leukocytes in chronic lymphatic leukemia].
Topics: Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes; Mechlorethamine; Nitrogen Must | 1960 |
The effect of mustargen mixed with urethan in the treatment of IRC leukemia in Fischer rats.
Topics: Animals; Leukemia; Leukemia, Experimental; Mechlorethamine; Nitrogen Mustard Compounds; Rats; Rats, | 1961 |
[Alteration of experimental mouse leukemia with nitrogen mustard phosphamide esters].
Topics: Animals; Dimethoate; Esters; Leukemia; Leukemia, Experimental; Mechlorethamine; Mice | 1961 |
[5-year clinical experience with Degranol].
Topics: Leukemia; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1962 |
Evaluation of the effectiveness of radioactive phosphorus and chlorambucil in patients with chronic lymphocytic leukemia.
Topics: Chlorambucil; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphocytes; Mec | 1962 |
Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
Topics: Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Minnesota; Nitrogen Mustard Compounds; Urac | 1962 |
Some immunologic aspects of the evolution and treatment of leukemia.
Topics: Animals; Biological Products; Busulfan; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compound | 1962 |
[Forms of leukosis and their therapy].
Topics: Adrenocorticotropic Hormone; Antineoplastic Agents; Busulfan; Colchicine; Folic Acid Antagonists; Go | 1963 |
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1963 |
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
Topics: Disease Management; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1962 |
[TUMOR-FORMING LEUKEMIA (INCLUDING CHLOROMA)].
Topics: Adolescent; Alanine; Antineoplastic Agents; Child; Dexamethasone; Humans; Leukemia; Mechlorethamine; | 1963 |
THE URIC ACID ANURIA OF LEUKEMIA TREATED BY DIALYSIS.
Topics: Adolescent; Anuria; Chlorambucil; Fluid Therapy; Humans; Kidney; Kidneys, Artificial; Leukemia; Mech | 1963 |
LEUKEMIA. AN ANALYSIS OF 209 CASES FROM THE ELLIS FISCHEL STATE CANCER HOSPITAL.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Busulfan; Cancer Care Facilit | 1963 |
[A CASE OF LEUKEMIA CUTIS].
Topics: Dactinomycin; Dermatology; Humans; Leukemia; Mechlorethamine; Pathology; Prednisolone; Skin; Skin Ne | 1963 |
THE EFFECT OF CHEMOTHERAPEUTIC AGENTS UPON THE METABOLISM OF INTACT HUMAN CANCER CELLS: AN IN VITRO TECHNIC FOR CELL SENSITIVITY.
Topics: Aminopterin; Antineoplastic Agents; Azaguanine; Carbohydrate Metabolism; In Vitro Techniques; Lactat | 1963 |
[TUMOUR CHEMOTHERAPY. IX. NITROGEN MUSTARDS OF PHOSPHORAMIDE, PHOSPHORAMIDE ESTER AND THIOESTER].
Topics: Animals; Fibrosarcoma; Leukemia; Leukemia, Experimental; Mechlorethamine; Mice; Neoplasms; Nitrogen | 1962 |
RESISTANCE OF PHYTOHAEMAGGLUTININ-TREATED LYMPHOCYTES TO X-RAYS AND NITROGEN MUSTARD.
Topics: Antibodies; Biochemical Phenomena; Humans; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mechlorethamin | 1963 |
EFFECT OF ADMINISTRATION OF ALKYLATING AGENTS OR 6-MERCAPTOPURINE ON SERUM LEVEL OF DEOXYRIBONUCLEASE I IN LEUKEMIA PATIENTS.
Topics: Alkylating Agents; Blood Chemical Analysis; Busulfan; Deoxyribonuclease I; DNA; Humans; Leukemia; Le | 1963 |
CHRONIC LYMPHATIC LEUKAEMIA AND ITS MANAGEMENT.
Topics: Adrenal Cortex Hormones; Chlorambucil; Geriatrics; Humans; Leukemia; Leukemia, Lymphoid; Mechloretha | 1963 |
[IMPROVEMENT AND EXACERBATION IN LEUKEMIA].
Topics: Aminocaproates; Aminocaproic Acid; Anemia; Antineoplastic Agents; Blood Transfusion; Busulfan; Centr | 1963 |
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky | 1964 |
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
Topics: Anemia; Anemia, Hemolytic; Betamethasone; Chlorambucil; Dexamethasone; Geriatrics; Humans; Leukemia; | 1964 |
PHAGOCYTOSIS IN RETICULUM CELL SARCOMA.
Topics: Adolescent; Black People; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Leukemia; | 1964 |
COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
Topics: Animals; Benzaldehydes; Carcinoma, Bronchogenic; Carcinoma, Hepatocellular; Female; Humans; Injectio | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
LYMPHANGIOGRAPHY FOR MALIGNANT DISEASES IN CHILDREN.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Myeloid; Lymph Nodes; Lympha | 1964 |
SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY.
Topics: Animals; Chemistry, Pharmaceutical; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymp | 1963 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human | 1964 |
SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. V. TETRAZOLIUM NITROGEN MUSTARDS.
Topics: Animals; Carcinoma; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Leukemia; Leukemia, Experiment | 1963 |
MODIFICATION OF THE RADIATION EFFECT ON ASCITIC TUMOUR CELLS BY PHARMACOLOGICAL AGENTS INJECTED INTRAVENOUSLY.
Topics: beta-Aminoethyl Isothiourea; Glutathione; Injections; Injections, Intravenous; Leukemia; Leukemia, E | 1964 |
TUMOR INCIDENCE IN A-STRAIN MICE.
Topics: Cyclophosphamide; Incidence; Leukemia; Leukemia, Radiation-Induced; Lung Neoplasms; Mechlorethamine; | 1965 |
ASSOCIATION OF HERPES ZOSTER WITH LEUKEMIA AND LYMPHOMA IN CHILDREN.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Child; Cyclophosphamide; Drug Therapy; Herpes Zoster; Ho | 1965 |
RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH.
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Therapy; Ganglioneuroma; Gastroin | 1965 |
FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
Topics: Aging; Busulfan; Cataract; Female; Humans; Leukemia; Leukemia, Myeloid; Longevity; Lung Neoplasms; L | 1965 |
EXPECTANCY FOR LIFE IN CHRONIC LYMPHATIC LEUKEMIA.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Child; Chlorambucil; Cyclophospha | 1965 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu | 1965 |
[Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphatic Vessels; Mechlorethamine | 1952 |
Treatment of malignant lymphomas and lymphadenoses with leukeran.
Topics: Chlorambucil; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Nitrogen Mus | 1959 |
CB 1348 therapy in leukemia and allied diseases.
Topics: Arylsulfonates; Chlorambucil; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
New nitrogen mustards in the control of leukemia.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
Clinical evaluation of the effect of degranol.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mannitol; Mannomustine; Mechlorethamine; | 1959 |
[Comparative studies on the effect of dimethanesulfonyl-D-mannitol and mannitol mustard on animal leukemia].
Topics: Leukemia; Leukemia, Experimental; Mannitol; Mannomustine; Mechlorethamine; Nitrogen Mustard Compound | 1962 |
Uracil mustard therapy in acute leukemia in children.
Topics: Acute Disease; Child; Infant; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Uracil Mustard | 1962 |
Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364.
Topics: Antineoplastic Agents; Chlorambucil; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Mechlo | 1962 |
Current control of the chronic leukemias with nitrogen mustards.
Topics: Chronic Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1961 |
Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; | 1962 |
Nitrogen mustards in the treatment of neoplastic disease.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis | 1950 |
[Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoidosis; Uret | 1950 |
[Nitrogen mustard therapy of malignant tumors].
Topics: Carcinoma; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1950 |
Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
Chemotherapy of leukemia. III. Further studies on the effect of nitrogen mustards and related compounds on transmitted mouse leukemia.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Clinical experiences with nitrogen mustards].
Topics: Erythema; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1951 |
[Chloronaphthylamine in the treatment of malignant lymphogranuloma and chronic leukemia].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1950 |
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
Topics: Amines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1951 |
[Multiple successive and simultaneous treatment in a case of chronic myeloid leukemia].
Topics: Chloramines; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Mechlore | 1951 |
[Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compou | 1951 |
The principles of radiation therapy of lymphoblastoma.
Topics: Hodgkin Disease; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1951 |
[Preliminary results of combined urethane, nitrogen mustard and Delbet's vaccine therapy of chronic myelocytic leukemias].
Topics: Humans; Immunotherapy, Active; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, | 1951 |
Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1951 |
Precipitous leucopenia in a N-mustard treated leukemia; (an autopsy case).
Topics: Autopsy; Humans; Leukemia; Leukemia, Myeloid; Leukopenia; Mechlorethamine; Mustard Plant; Nitrogen M | 1951 |
[Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1951 |
[Chloroalkylamines and acute leukemia; clinical and histopathological study of methyl-bis (beta chloroethyl) amine hydrochloride in acute hemocytoblastic leukosis].
Topics: Amines; Humans; Leukemia; Leukocytes; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
Chemotherapy in the reticuloses.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids; Phosphorus; | 1952 |
[Treatment of malignant lymphogranuloma and chronic leukemia with chloroethylnaphthylamine].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Treatment of leukemia with urethane and nitrogen mustards].
Topics: Humans; Leukemia; Leukemia, Myeloid; Mechlorethamine; Nitrogen Mustard Compounds; Urethane | 1951 |
Alkylamines in the treatment of leukaemia.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
[Problems of leucocyte metabolism. III. Effects of nitrogen mustard and nitrogen mustard in combination with urethan on the metabolism of cells of myeloid leukemia].
Topics: Humans; Leukemia; Leukemia, Myeloid; Leukocytes; Mechlorethamine; Nitrogen Mustard Compounds; Uretha | 1952 |
Leukemic lymphosarcoma, lymphosarcomatosis; remarkable but transitory efficiency of the nitrided perite.
Topics: Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1949 |
On treatment of spontaneous leukemia in mice with nitrogenized mustard gas.
Topics: Animals; Leukemia; Mechlorethamine; Mice; Mustard Gas; Nitrogen Mustard Compounds | 1950 |
[Action of chloramine in two cases of leukemic myelosis and in a case of malignant lymphogranuloma].
Topics: Chloramines; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.
Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; | 1950 |
The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias.
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1950 |
[Malignant growth and pharmacotherapy].
Topics: Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma; Urethane | 1950 |
Nitrogen Mustards in Fowl Leucosis.
Topics: Animals; Birds; Humans; Leukemia; Meat; Mechlorethamine; Nitrogen Mustard Compounds | 1948 |
The nitrogen mustards in the treatment of leukemia.
Topics: Ethylamines; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
Topics: Amines; Ethylamines; Hodgkin Disease; Humans; Leukemia; Lung Diseases; Lung Neoplasms; Lymphoma; Lym | 1949 |
Nitrogen mustard in treatment of leukemias.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Daca | 1982 |
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne | 1984 |
[Various disputable problems of ambulatory treatment of tumors of the blood system].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Hodgkin | 1984 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
[Acute leukemias and solid tumors in the course of Hodgkin disease].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1983 |
Second malignancy complicating Hodgkin's disease.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycloph | 1983 |
Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1983 |
[10 years of DeVita protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[The current state of curability of Hodgkin's disease].
Topics: Chromosome Aberrations; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamin | 1981 |
2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
Topics: Cladribine; Cytarabine; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leuk | 1993 |
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Co | 1994 |
Differential inhibition of the DNA binding of transcription factors NF kappa B and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications.
Topics: Base Composition; Base Sequence; Chloramphenicol O-Acetyltransferase; DNA-Binding Proteins; HIV Long | 1993 |
Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.
Topics: Alkylating Agents; Animals; Blotting, Southern; Blotting, Western; Bone Marrow Transplantation; Chlo | 1996 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F | 2001 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 2001 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz | 2002 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; | 1977 |
Hematologic neoplasia in patients treated for Hodgkin's disease.
Topics: Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechloreth | 1977 |
Drug-induced stimulation of transport of hydrolyzed nitrogen mustard and choline by normal and leukemic human cells in vitro.
Topics: Biological Transport; Choline; Cocaine; Dose-Response Relationship, Drug; In Vitro Techniques; Leuke | 1976 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1992 |
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.
Topics: Cell Survival; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Ethacrynic Acid; Human | 1990 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 1991 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1988 |
[Acute leukemia in patients treated for Hodgkin's disease].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Human | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; D | 1987 |
[Myelodysplastic syndromes: a group of preleukemic disorders].
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia | 1987 |
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; | 1987 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot | 1985 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas | 1973 |
[Cytostatic effects on nucleic acid- and protein synthesis of benign and malignant lymphomas].
Topics: Amides; Antineoplastic Agents; Dactinomycin; DNA, Neoplasm; Hodgkin Disease; Humans; Hydralazine; In | 1967 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
Topics: Antineoplastic Agents; Blood Bactericidal Activity; Carmustine; Cell Membrane; Complement System Pro | 1974 |
Combination chemotherapy of acute leukemia and Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Predni | 1972 |
RNA metabolism in normal and leukaemic leucocytes: further studies on RNA synthesis.
Topics: Antimetabolites; Busulfan; Carbon Isotopes; Chromatography; Humans; Leukemia; Leukemia, Lymphoid; Le | 1968 |
[Results and current biological bases of therapy of malignant hemoreticulopathies].
Topics: Antineoplastic Agents; Chlorambucil; Cortisone; Cyclophosphamide; Humans; Hydrazines; Leukemia; Lymp | 1971 |
The use of combination therapy in leukemia remission.
Topics: Adolescent; Antineoplastic Agents; Central Nervous System Diseases; Child; Dactinomycin; Humans; Leu | 1969 |
Drugs and their abuse no. V--misuse of cytotoxic drugs.
Topics: Antineoplastic Agents; Cyclophosphamide; Fluorouracil; Humans; Leukemia; Mechlorethamine; Melphalan; | 1971 |
Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Topics: Adult; Antineoplastic Agents; Busulfan; Chlorambucil; Hodgkin Disease; Humans; Leukemia; Lymphoma; M | 1968 |